These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 10912772)
1. Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions. Egashira K; Ni W; Inoue S; Kataoka C; Kitamoto S; Koyanagi M; Takeshita A Hypertens Res; 2000 Jul; 23(4):353-8. PubMed ID: 10912772 [TBL] [Abstract][Full Text] [Related]
2. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Ni W; Egashira K; Kataoka C; Kitamoto S; Koyanagi M; Inoue S; Takeshita A Circ Res; 2001 Aug; 89(5):415-21. PubMed ID: 11532902 [TBL] [Abstract][Full Text] [Related]
3. Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats. Kitamoto S; Egashira K; Kataoka C; Koyanagi M; Katoh M; Shimokawa H; Morishita R; Kaneda Y; Sueishi K; Takeshita A Circulation; 2000 Aug; 102(7):806-12. PubMed ID: 10942751 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Tomita H; Egashira K; Kubo-Inoue M; Usui M; Koyanagi M; Shimokawa H; Takeya M; Yoshimura T; Takeshita A Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1456-64. PubMed ID: 9743235 [TBL] [Abstract][Full Text] [Related]
5. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192 [TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels. Martínez-González J; Alfón J; Berrozpe M; Badimon L Atherosclerosis; 2001 Nov; 159(1):27-33. PubMed ID: 11689203 [TBL] [Abstract][Full Text] [Related]
7. Role of transforming growth factor-beta1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis. Koyanagi M; Egashira K; Kubo-Inoue M; Usui M; Kitamoto S; Tomita H; Shimokawa H; Takeshita A Hypertension; 2000 Jan; 35(1 Pt 1):86-90. PubMed ID: 10642280 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Zhao Q; Egashira K; Inoue S; Usui M; Kitamoto S; Ni W; Ishibashi M; Hiasa Ki K; Ichiki T; Shibuya M; Takeshita A Circulation; 2002 Mar; 105(9):1110-5. PubMed ID: 11877364 [TBL] [Abstract][Full Text] [Related]
9. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155 [TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine. Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774 [TBL] [Abstract][Full Text] [Related]
12. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Kataoka C; Egashira K; Ishibashi M; Inoue S; Ni W; Hiasa K; Kitamoto S; Usui M; Takeshita A Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H768-74. PubMed ID: 14592942 [TBL] [Abstract][Full Text] [Related]
13. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Usui M; Egashira K; Tomita H; Koyanagi M; Katoh M; Shimokawa H; Takeya M; Yoshimura T; Matsushima K; Takeshita A Circulation; 2000 Jan; 101(3):305-10. PubMed ID: 10645927 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates. Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560 [TBL] [Abstract][Full Text] [Related]
15. Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats. Coelho-Filho OR; De Luca IM; Tanus-Santos JE; Cittadino M; Sampaio RC; Coelho OR; Hyslop S; Moreno Júnior H Int J Cardiol; 2001 Jul; 79(2-3):215-21. PubMed ID: 11461744 [TBL] [Abstract][Full Text] [Related]
16. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Koyanagi M; Egashira K; Kitamoto S; Ni W; Shimokawa H; Takeya M; Yoshimura T; Takeshita A Circulation; 2000 Oct; 102(18):2243-8. PubMed ID: 11056100 [TBL] [Abstract][Full Text] [Related]
17. Pravastatin affects blood pressure and vascular reactivity. Li N; Sawamura M; Nara Y; Ikeda K; Yamori Y Heart Vessels; 1996; 11(2):64-8. PubMed ID: 8836753 [TBL] [Abstract][Full Text] [Related]
19. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats. Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats. Minamino T; Kitakaze M; Papst PJ; Ueda Y; Sakata Y; Asanuma H; Ogai A; Kuzuya T; Terada N; Hori M Cardiovasc Drugs Ther; 2000 Oct; 14(5):533-42. PubMed ID: 11101202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]